Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Things You Can Expect in Gilead Sciences' Q2 Update

TheMotleyFool 
0 0 24.07.17
3 Things You Can Expect in Gilead Sciences' Q2 Update
 
3 Things You Can Expect in Gilead Sciences' Q2 Update

When Gilead Sciences (NASDAQ: GILD) reported its first-quarter results in May, expectations were low. The biotech didn't surprise anyone with dramatically lower revenue and earnings than the prior-year period, with plunging hepatitis-C franchise sales.

Gilead steps up to the plate again soon, with the release of its second-quarter results scheduled for July 26 after the market closes. What will be the highlights of the company's update? Here are three things you can expect.

Image source: Getty Images.

Continue reading


Source: Fool.com

Gilead Sciences Inc Stock

€70.94
0.440%
The Gilead Sciences Inc stock is trending slightly upwards today, with an increase of €0.31 (0.440%) compared to yesterday's price.
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 85 € shows a slightly positive potential of 19.82% compared to the current price of 70.94 € for Gilead Sciences Inc.
Show more
Like: 0
GILD
Share

Comments

Not a member yet? Sign up for free!